{
    "2018-03-28": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Bristol-Myers Squibbâ€™s Valuation in March 2018",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "valuation"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "When Will They Learn? 4 Huge Biotech Blowups",
                "features": {
                    "keywords": [
                        "biotech",
                        "blowups"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV)",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "dividend",
                        "yield"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "It's Not Final 4 But WashU, Wisconsin Fight on Other Court",
                "features": {
                    "keywords": [
                        "WashU",
                        "Wisconsin",
                        "fight",
                        "court"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "3 Biotechs That Could Get Big Boosts in April",
                "features": {
                    "keywords": [
                        "biotechs",
                        "boosts",
                        "April"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-28",
                "original_text": "Validea Peter Lynch Strategy Daily Upgrade Report - 3/28/2018",
                "features": {
                    "keywords": [
                        "Validea",
                        "Peter Lynch",
                        "strategy",
                        "upgrade"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Biotech Stocks Facing FDA Decision In April",
                "features": {
                    "keywords": [
                        "biotech",
                        "FDA",
                        "decision"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}